Azenta, Inc. (AZTA) |
|
42.1 0.5 (1.2%)
|
03-24 16:00 |
|
Open: |
41.24 |
Pre. Close: |
41.6 |
|
High:
|
42.28 |
Low:
|
40.92 |
|
Volume:
|
1,143,094 |
Market Cap:
|
2,909(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 4:24:15 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 50.7  One year: 54.53 |
| Support: |
Support1: 38.09 Support2: 31.69 |
| Resistance: |
Resistance1: 43.4 Resistance2: 46.68 |
| Pivot: |
41.36 |
| Moving Average: |
MA(5): 41.3  MA(20): 42.06
MA(100): 52.27 MA(250): 59.36 |
| MACD: |
MACD(12,26): -2 Signal(9): -2.6 |
| Stochastic oscillator: |
%K(14,3): 51.2 %D(3): 46.9 |
| RSI: |
RSI(14): 41.2 |
| 52-week: |
High: 86.54 Low: 37.61 |
| Average Vol(K): |
3-Month: 1,079 (K) 10-Days: 1,410 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AZTA ] has closed below upper band by 36.3%. Bollinger Bands are 49.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
42.33 - 42.49 |
42.49 - 42.62 |
|
Low:
|
40.5 - 40.7 |
40.7 - 40.85 |
|
Close:
|
41.8 - 42.11 |
42.11 - 42.36 |
|
Company Description |
|
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts. |
Headline News |
Sun, 26 Mar 2023
Coldstream Capital Management Inc. Purchases Shares of 3626 ... - MarketBeat
Tue, 21 Mar 2023
First Week of AZTA October 20th Options Trading - Nasdaq
Mon, 20 Mar 2023
Moody's National Bank Trust Division increases its stake in Azenta ... - Best Stocks
Sun, 19 Mar 2023
Moody National Bank Trust Division Boosts Holdings in Azenta, Inc ... - MarketBeat
Sun, 12 Mar 2023
Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Pier Capital LLC - MarketBeat
Thu, 09 Mar 2023
UBS Group AG Has $1.77 Million Position in Azenta, Inc. (NASDAQ ... - MarketBeat
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
69 (M) |
| Shares Float |
68 (M) |
|
% Held by Insiders
|
1.7 (%) |
|
% Held by Institutions
|
108.1 (%) |
|
Shares Short
|
3,970 (K) |
|
Shares Short P.Month
|
6,510 (K) |
Stock Financials |
|
EPS
|
-0.34 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
41.58 |
|
Profit Margin (%)
|
349.7 |
|
Operating Margin (%)
|
-8.5 |
|
Return on Assets (ttm)
|
-1.3 |
|
Return on Equity (ttm)
|
-1.3 |
|
Qtrly Rev. Growth
|
27.7 |
|
Gross Profit (p.s.)
|
3.69 |
|
Sales Per Share
|
8.59 |
|
EBITDA (p.s.)
|
0.15 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-509 (M) |
|
Levered Free Cash Flow
|
-36 (M) |
Stock Valuations |
|
PE Ratio
|
-127.58 |
|
PEG Ratio
|
11.8 |
|
Price to Book value
|
1.01 |
|
Price to Sales
|
4.89 |
|
Price to Cash Flow
|
-5.72 |
Stock Dividends |
|
Dividend
|
0.1 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0.2% |
|
Dividend Pay Date
|
2021-12-22 |
|
Ex-Dividend Date
|
2021-12-01 |
|
Your Ad Here
|
|
